Clinical Trial Update: Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the NO-synthase inhibitor VAS203 effects on renal function in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Function Impairment in Healthy Volunteers

Drugs mentioned

• VAS203

Snippet

Sponsor: veriNOS operations GmbH | Conditions: Renal Function Impairment in Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2019-08-09